Scotts Miracle-Gro Company (SMG) reported $3.48B of revenue for the twelve months ended Jun 27, 2026. That is up 4.6% from the year before. Revenue for fiscal 2025 was $3.41B.

Yes. Scotts Miracle-Gro Company earned $73.90M in net income for the twelve months ended Jun 27, 2026, a net margin of 2.1%.

How much cash and debt does SMG have?

Scotts Miracle-Gro Company reported $27.70M in cash and cash equivalents and $2.11B of debt on its most recent balance sheet in SEC filings.

How fast is SMG revenue growing?

Scotts Miracle-Gro Company's revenue changed -3.9% in fiscal 2025, to $3.41B. Its compound annual growth rate was -3.7% over 5 years and +3.7% over 10 years.

What is SMG gross margin?

Scotts Miracle-Gro Company's gross profit was $1.11B on $3.48B of revenue for the twelve months ended Jun 27, 2026, a gross margin of 31.8%.

What is SMG free cash flow?

Scotts Miracle-Gro Company generated $263.30M of free cash flow for the twelve months ended Jun 27, 2026, which is operating cash flow of $369.30M less capital expenditures.

What is SMG earnings per share?

Diluted earnings per share were $1.20 for the twelve months ended Jun 27, 2026, from SEC filings, restated for any stock split those filings show.

When did SMG last report financial results?

The latest statements here come from Scotts Miracle-Gro Company's 10-Q filed on Aug 5, 2026, covering the period ended Jun 27, 2026.

Financials · SMG

Scotts Miracle-Gro Company (SMG) financials

For the twelve months ended Jun 27, 2026, Scotts Miracle-Gro Company reported $3.48B of revenue and $73.90M of net income.

Revenue, TTM: $3.48B
Revenue growth, YoY: +4.6%
Net income, TTM: $73.90M
Net income growth, YoY: +39.2%
Net margin: 2.1%
Free cash flow, TTM: $263.30M
EPS, diluted, TTM: $1.20
EPS growth, YoY: +42.9%
Cash: $27.70M
Total debt: $2.11B
P/E: 50.98
P/S: 1.08
Market cap: $3.77B

Annual revenue$3.41B

FY2016FY2025

Annual net income$145.20M

FY2016FY2025

Annual free cash flow$273.90M

FY2016FY2025

SMG revenue and earnings growth

SMG revenueQ3 2026$1.17B

Quarter YoY: +1.1%
QoQ: -19.7%
FY YoY: -3.9%
5Y CAGR: -3.7%
10Y CAGR: +3.7%

SMG revenue was $1.17B in fiscal Q3 2026 (ended Jun 27, 2026), up 1.1% from a year earlier and down 19.7% from the prior quarter. For the full fiscal 2025 it was $3.41B, down 3.9% from fiscal 2024. Compound annual growth was -3.7% over 5 years and +3.7% over 10 years. It rose in 7 of the last 10 fiscal years.

SMG net incomeQ3 2026$112.20M

Quarter YoY: -24.7%
QoQ: -53.0%
5Y CAGR: -17.8%
10Y CAGR: -1.0%

SMG net income was $112.20M in fiscal Q3 2026 (ended Jun 27, 2026), down 24.7% from a year earlier and down 53.0% from the prior quarter. For the full fiscal 2025 it was $145.20M, compared with -$34.90M in fiscal 2024. Compound annual growth was -17.8% over 5 years and -1.0% over 10 years.

SMG EPSQ3 2026$1.90

Quarter YoY: -25.2%
QoQ: -53.0%
5Y CAGR: -18.4%
10Y CAGR: -0.4%

SMG diluted EPS was $1.90 in fiscal Q3 2026 (ended Jun 27, 2026), down 25.2% from a year earlier and down 53.0% from the prior quarter. For the full fiscal 2025 it was $2.47, compared with -$0.61 in fiscal 2024. Compound annual growth was -18.4% over 5 years and -0.4% over 10 years.

SMG free cash flowQ3 2026$321.10M

Quarter YoY: -26.6%
QoQ: +59.4%
FY YoY: -53.1%
5Y CAGR: -11.2%
10Y CAGR: +4.0%

SMG free cash flow was $321.10M in fiscal Q3 2026 (ended Jun 27, 2026), down 26.6% from a year earlier and up 59.4% from the prior quarter. For the full fiscal 2025 it was $273.90M, down 53.1% from fiscal 2024. Compound annual growth was -11.2% over 5 years and +4.0% over 10 years.

Export CSV

Income statement

Income statement
Line item	FY2025 Sep 30, 2025	FY2024 Sep 30, 2024	FY2023 Sep 30, 2023	FY2022 Sep 30, 2022	FY2021 Sep 30, 2021	FY2020 Sep 30, 2020	FY2019 Sep 30, 2019	FY2018 Sep 30, 2018	FY2017 Sep 30, 2017	FY2016 Sep 30, 2016
Revenue	$3.41B	$3.55B	$3.55B	$3.92B	$4.92B	$4.13B	$3.16B	$2.66B	$2.64B	$2.51B
Cost of revenue	$2.35B	$2.62B	$2.71B	$2.89B	$3.43B	$2.77B	$2.13B	$1.78B	$1.67B	$1.60B
Gross profit	$1.04B	$850.50M	$657.30M	$872.90M	$1.47B	$1.35B	$1.02B	$864.60M	$972.60M	$900.30M
Research and development	$34.80M	$34.60M	$35.70M	$45.30M	$45.40M	$39.70M	$39.60M	$42.50M	$39.90M	$36.00M
Selling, general and admin	$603.40M	$559.00M	$551.30M	$613.00M	$743.50M	$757.80M	$601.30M	$540.10M	$550.90M	$518.00M
Operating income	$358.60M	$208.80M	-$174.40M	-$434.00M	$723.00M	$585.20M	$409.60M	$198.90M	$433.40M	$447.60M
Interest expense	$128.80M	$158.80M	$178.10M	$118.10M	$78.90M	$79.60M	$101.80M	$86.40M	$76.10M	$62.90M
Pre-tax income	$221.70M	-$23.60M	-$453.30M	-$558.10M	$677.10M	$510.60M	$581.60M	$115.70M	$314.90M	$383.70M
Income tax	$76.50M	$11.30M	-$73.20M	-$120.60M	$159.80M	$123.70M	$144.90M	-$11.90M	$116.60M	$137.60M
Net income	$145.20M	-$34.90M	-$380.10M	-$437.50M	$512.50M	$387.40M	$460.70M	$63.70M	$218.30M	$315.30M
EPS, basic	$2.52	-$0.61	-$6.79	-$7.88	$9.20	$6.96	$8.30	$1.13	$3.68	$5.16
EPS, diluted	$2.47	-$0.61	-$6.79	-$7.88	$8.96	$6.81	$8.18	$1.12	$3.63	$5.09
Diluted shares	58.7M	56.8M	56.0M	55.5M	57.2M	56.9M	56.3M	57.1M	60.2M	62.0M

Balance sheet

Balance sheet
Line item	FY2025 Sep 30, 2025	FY2024 Sep 30, 2024	FY2023 Sep 30, 2023	FY2022 Sep 30, 2022	FY2021 Sep 30, 2021	FY2020 Sep 30, 2020	FY2019 Sep 30, 2019	FY2018 Sep 30, 2018	FY2017 Sep 30, 2017	FY2016 Sep 30, 2016
Cash and equivalents	$32.80M	$71.60M	$31.90M	$86.80M	$244.10M	$16.60M	$18.80M	$33.90M	$120.50M	$28.60M
Receivables	$160.80M	$176.80M	$304.20M	$299.00M	$483.40M	$474.80M	$223.90M	$226.00M	$197.70M	$127.00M
Inventory	$542.70M	$587.50M	$880.30M	$1.34B	$1.13B	$621.90M	$540.30M	$481.40M	$407.50M	$394.70M
Current assets	$940.30M	$980.40M	$1.40B	$1.98B	$2.02B	$1.22B	$1.04B	$885.70M	$881.70M	$1.03B
Goodwill	$243.90M	$243.90M	$243.90M	$254.00M	$605.20M	$544.10M	$538.70M	$543.00M	$441.60M	$371.90M
Total assets	$2.74B	$2.87B	$3.41B	$4.30B	$4.80B	$3.38B	$3.03B	$3.05B	$2.75B	$2.76B
Current liabilities	$739.70M	$750.30M	$773.70M	$963.90M	$1.14B	$950.40M	$620.50M	$612.70M	$544.50M	$707.10M
Short-term debt	$57.20M	$52.60M	$52.30M	$144.30M	$57.80M	$66.40M	$128.10M	$132.60M	$143.10M	$185.00M
Long-term debt	$2.05B	$2.17B	$2.56B	$2.83B	$2.24B	$1.46B	$1.52B	$1.88B	$1.26B	$1.03B
Total debt	$2.11B	$2.23B	$2.61B	$2.97B	$2.29B	$1.52B	$1.65B	$2.02B	$1.40B	$1.22B
Total liabilities	$3.10B	$3.26B	$3.68B	$4.15B	$3.79B	$2.68B	$2.31B	$2.69B	$2.09B	$2.02B
Shareholders' equity	-$357.50M	-$390.60M	-$267.30M	$147.70M	$1.01B	$702.90M	$723.20M	$359.60M	$661.70M	$734.30M

Cash flow

Cash flow
Line item	FY2025 Sep 30, 2025	FY2024 Sep 30, 2024	FY2023 Sep 30, 2023	FY2022 Sep 30, 2022	FY2021 Sep 30, 2021	FY2020 Sep 30, 2020	FY2019 Sep 30, 2019	FY2018 Sep 30, 2018	FY2017 Sep 30, 2017	FY2016 Sep 30, 2016
Operating cash flow	$371.30M	$667.50M	$531.00M	-$129.00M	$271.50M	$558.00M	$226.80M	$342.50M	$363.20M	$244.00M
Capital expenditures	$97.40M	$84.00M	$92.80M	$113.50M	$106.90M	$62.70M	$42.40M	$68.20M	$69.60M	$58.30M
Free cash flow	$273.90M	$583.50M	$438.20M	-$242.50M	$164.60M	$495.30M	$184.40M	$274.30M	$293.60M	$185.70M
Investing cash flow	-$112.10M	-$100.40M	-$65.70M	-$283.20M	-$538.60M	$46.90M	$255.20M	-$580.70M	$22.40M	-$134.40M
Financing cash flow	-$294.00M	-$527.90M	-$520.10M	$255.30M	$494.00M	-$607.10M	-$496.50M	$151.20M	-$316.80M	-$128.80M
Dividends paid	$154.30M	$151.30M	$149.10M	$166.20M	$143.00M	$411.20M	$124.50M	$120.00M	$120.30M	$116.60M
Share repurchases	$18.40M	$5.10M	$9.30M	$257.90M	$129.30M	$53.20M	$3.10M	$327.70M	$255.20M	$137.40M
Stock-based compensation	$69.00M	$80.40M	$68.90M	$34.30M	$40.60M	$57.90M	$38.40M	$40.40M	$25.20M	$15.60M
Depreciation and amortization	-	$80.60M	$92.50M	$105.20M	$93.80M	$94.70M	$89.30M	$83.40M	$73.80M	$62.30M

Key ratios

Key ratios
Line item	FY2025 Sep 30, 2025	FY2024 Sep 30, 2024	FY2023 Sep 30, 2023	FY2022 Sep 30, 2022	FY2021 Sep 30, 2021	FY2020 Sep 30, 2020	FY2019 Sep 30, 2019	FY2018 Sep 30, 2018	FY2017 Sep 30, 2017	FY2016 Sep 30, 2016
Revenue growth, YoY	-3.9%	0.0%	-9.5%	-20.3%	19.2%	30.9%	18.5%	0.8%	5.4%	5.7%
Net income growth, YoY	-	-	-	-	32.3%	-15.9%	623.2%	-70.8%	-30.8%	97.3%
EPS growth, YoY	-	-	-	-	31.6%	-16.7%	630.4%	-69.1%	-28.7%	98.1%
Gross margin	30.6%	23.9%	18.5%	22.2%	29.8%	32.6%	32.3%	32.5%	36.8%	35.9%
Operating margin	10.5%	5.9%	-4.9%	-11.1%	14.7%	14.2%	13.0%	7.5%	16.4%	17.9%
Net margin	4.3%	-1.0%	-10.7%	-11.1%	10.4%	9.4%	14.6%	2.4%	8.3%	12.6%
Free cash flow margin	8.0%	16.4%	12.3%	-6.2%	3.3%	12.0%	5.8%	10.3%	11.1%	7.4%
Return on equity	-	-	-	-296.2%	50.6%	55.1%	63.7%	17.7%	33.0%	42.9%
Return on assets	5.3%	-1.2%	-11.1%	-10.2%	10.7%	11.5%	15.2%	2.1%	7.9%	11.4%
Current ratio	1.27	1.31	1.81	2.06	1.77	1.28	1.68	1.45	1.62	1.46
Debt to equity	-	-	-	20.11	2.26	2.16	2.28	5.61	2.12	1.66

Income statement

Income statement
Line item	Q3 2026 Jun 27, 2026	Q2 2026 Mar 28, 2026	Q1 2026 Dec 27, 2025	Q4 2025* Sep 30, 2025	Q3 2025 Jun 28, 2025	Q2 2025 Mar 29, 2025	Q1 2025 Dec 28, 2024	Q4 2024* Sep 30, 2024	Q3 2024 Jun 29, 2024	Q2 2024 Mar 30, 2024	Q1 2024 Dec 30, 2023	Q4 2023* Sep 30, 2023
Revenue	$1.17B	$1.46B	$354.40M	$497.40M	$1.16B	$1.39B	$366.60M	$414.70M	$1.20B	$1.53B	$410.40M	$374.50M
Cost of revenue	$805.00M	$849.00M	$264.40M	$444.80M	$784.60M	$842.30M	$276.70M	$427.30M	$850.60M	$986.80M	$354.00M	$407.60M
Gross profit	$365.90M	$610.50M	$88.70M	$40.90M	$372.70M	$542.10M	$88.50M	-$29.50M	$354.10M	$463.70M	$62.20M	-$57.00M
Selling, general and admin	$145.60M	$199.20M	$106.00M	$167.20M	$144.80M	$177.80M	$113.50M	$117.60M	$147.90M	$178.70M	$114.80M	$108.00M
Operating income	$169.60M	$401.80M	-$21.80M	-$167.10M	$221.80M	$349.70M	-$45.80M	-$216.10M	$200.10M	$272.10M	-$47.30M	-$416.10M
Interest expense	$28.00M	$31.30M	$27.20M	$26.60M	$31.80M	$36.60M	$33.90M	$33.20M	$38.80M	$44.10M	$42.80M	$40.00M
Pre-tax income	$155.20M	$364.90M	-$63.30M	-$207.40M	$214.00M	$306.00M	-$90.90M	-$312.20M	$183.00M	$219.80M	-$114.20M	-$560.60M
Income tax	$51.60M	$101.60M	-$15.50M	-$43.20M	$59.30M	$85.30M	-$24.80M	-$68.20M	$50.90M	$62.30M	-$33.70M	-$92.20M
Net income	$112.20M	$238.60M	-$125.00M	-$151.90M	$149.10M	$217.50M	-$69.50M	-$244.00M	$132.10M	$157.50M	-$80.50M	-$468.40M
EPS, basic	$1.93	$4.11	-$2.16	-$2.63	$2.58	$3.78	-$1.21	-$4.29	$2.33	$2.77	-$1.42	-$8.35
EPS, diluted	$1.90	$4.04	-$2.16	-$2.58	$2.54	$3.72	-$1.21	-$4.21	$2.28	$2.74	-$1.42	-$8.33
Diluted shares	59.2M	59.1M	57.9M	-	58.6M	58.4M	57.3M	-	58.0M	57.4M	56.7M	-

Balance sheet

Balance sheet
Line item	Q3 2026 Jun 27, 2026	Q2 2026 Mar 28, 2026	Q1 2026 Dec 27, 2025	Q4 2025* Sep 30, 2025	Q3 2025 Jun 28, 2025	Q2 2025 Mar 29, 2025	Q1 2025 Dec 28, 2024	Q4 2024* Sep 30, 2024	Q3 2024 Jun 29, 2024	Q2 2024 Mar 30, 2024	Q1 2024 Dec 30, 2023	Q4 2023* Sep 30, 2023
Cash and equivalents	$27.70M	$6.20M	$8.30M	$32.80M	$39.60M	$8.70M	$5.70M	$71.60M	$279.90M	$65.10M	$10.40M	$31.90M
Receivables	$713.00M	$766.70M	$193.80M	$160.80M	$545.70M	$767.80M	$173.00M	$176.80M	$504.60M	$876.90M	$287.60M	$304.20M
Inventory	$481.40M	$696.00M	$846.70M	$542.70M	$485.40M	$709.60M	$844.90M	$587.50M	$606.80M	$824.30M	$1.17B	$880.30M
Current assets	$1.35B	$1.62B	$1.26B	$940.30M	$1.28B	$1.73B	$1.29B	$980.40M	$1.54B	$1.94B	$1.68B	$1.40B
Goodwill	$243.90M	$243.90M	$243.90M	$243.90M	$243.90M	$243.90M	$243.90M	$243.90M	$243.90M	$243.90M	$243.90M	$243.90M
Total assets	$3.17B	$3.41B	$3.03B	$2.74B	$3.09B	$3.54B	$3.17B	$2.87B	$3.49B	$3.92B	$3.72B	$3.41B
Current liabilities	$1.11B	$1.28B	$932.40M	$739.70M	$798.60M	$1.01B	$683.80M	$750.30M	$854.40M	$1.06B	$764.10M	$773.70M
Short-term debt	$277.00M	$279.40M	$278.30M	$57.20M	$52.10M	$54.60M	$54.60M	$52.60M	$52.90M	$57.80M	$54.50M	$52.30M
Long-term debt	$1.84B	$2.07B	$2.25B	$2.05B	$2.14B	$2.49B	$2.64B	$2.17B	$2.44B	$2.76B	$2.97B	$2.56B
Total debt	$2.11B	$2.35B	$2.53B	$2.11B	$2.19B	$2.55B	$2.69B	$2.23B	$2.49B	$2.82B	$3.02B	$2.61B
Total liabilities	$3.38B	$3.70B	$3.53B	$3.10B	$3.26B	$3.83B	$3.65B	$3.26B	$3.64B	$4.18B	$4.10B	$3.68B
Shareholders' equity	-$208.70M	-$286.50M	-$500.60M	-$357.50M	-$170.90M	-$290.10M	-$479.50M	-$390.60M	-$146.20M	-$250.90M	-$385.40M	-$267.30M

Cash flow

Cash flow
Line item	Q3 2026 Jun 27, 2026	Q2 2026 Mar 28, 2026	Q1 2026 Dec 27, 2025	Q4 2025* Sep 30, 2025	Q3 2025 Jun 28, 2025	Q2 2025 Mar 29, 2025	Q1 2025 Dec 28, 2024	Q4 2024* Sep 30, 2024	Q3 2024 Jun 29, 2024	Q2 2024 Mar 30, 2024	Q1 2024 Dec 30, 2023	Q4 2023* Sep 30, 2023
Operating cash flow	$345.60M	$220.00M	-$370.40M	$174.10M	$454.40M	$188.10M	-$445.30M	$118.50M	$588.00M	$304.20M	-$343.20M	$535.30M
Capital expenditures	$24.50M	$18.60M	$20.00M	$42.90M	$16.90M	$8.30M	$29.30M	$16.60M	$13.20M	$16.30M	$37.90M	$19.00M
Free cash flow	$321.10M	$201.40M	-$390.40M	$131.20M	$437.50M	$179.80M	-$474.60M	$101.90M	$574.80M	$287.90M	-$381.10M	$516.30M
Investing cash flow	-$56.70M	-$23.60M	-$21.80M	-$52.10M	-$25.30M	-$11.40M	-$23.30M	-$20.40M	-$8.90M	-$17.90M	-$53.20M	-$21.10M
Financing cash flow	-$270.00M	-$198.60M	$366.80M	-$135.80M	-$396.10M	-$169.80M	$407.70M	-$306.80M	-$363.90M	-$231.40M	$374.20M	-$509.10M
Dividends paid	$38.50M	$39.50M	$38.30M	$38.10M	$38.20M	$38.80M	$39.20M	$37.60M	$37.50M	$38.80M	$37.40M	$37.10M
Share repurchases	$500.0K	$3.30M	$8.30M	$0	$100.0K	$2.70M	$15.60M	$100.0K	$100.0K	$1.80M	$3.10M	$0
Stock-based compensation	$12.00M	$18.90M	$7.40M	$13.40M	$17.50M	$22.60M	$15.50M	$14.70M	$21.10M	$28.60M	$16.00M	$16.20M

Key ratios

Key ratios
Line item	Q3 2026 Jun 27, 2026	Q2 2026 Mar 28, 2026	Q1 2026 Dec 27, 2025	Q4 2025* Sep 30, 2025	Q3 2025 Jun 28, 2025	Q2 2025 Mar 29, 2025	Q1 2025 Dec 28, 2024	Q4 2024* Sep 30, 2024	Q3 2024 Jun 29, 2024	Q2 2024 Mar 30, 2024	Q1 2024 Dec 30, 2023	Q4 2023* Sep 30, 2023
Revenue growth, YoY	1.1%	5.0%	-3.3%	19.9%	-3.6%	-8.9%	-10.7%	10.7%	7.5%	-0.4%	-22.1%	-24.1%
Net income growth, YoY	-24.7%	9.7%	-	-	12.9%	38.1%	-	-	202.3%	44.0%	-	-
EPS growth, YoY	-25.2%	8.6%	-	-	11.4%	35.8%	-	-	196.1%	41.2%	-	-
Gross margin	31.2%	41.8%	25.0%	8.2%	32.1%	39.0%	24.1%	-7.1%	29.5%	30.4%	15.2%	-15.2%
Operating margin	14.5%	27.5%	-6.2%	-33.6%	19.1%	25.2%	-12.5%	-52.1%	16.6%	17.8%	-11.5%	-111.1%
Net margin	9.6%	16.3%	-35.3%	-30.5%	12.9%	15.7%	-19.0%	-58.8%	11.0%	10.3%	-19.6%	-125.1%
Free cash flow margin	27.4%	13.8%	-110.2%	26.4%	37.7%	12.9%	-129.5%	24.6%	47.8%	18.9%	-92.9%	137.9%
Current ratio	1.21	1.27	1.35	1.27	1.61	1.71	1.88	1.31	1.80	1.83	2.20	1.81

Source: XBRL data Scotts Miracle-Gro Company files with the SEC, latest filing dated Aug 5, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

SMG peers

Company	Revenue	Growth	Net income	Net margin	Market cap
SMG	$3.48B	+4.6%	$73.90M	2.1%	$3.77B
NTRNutrien Ltd.	$26.89B	+3.5%	$2.27B	8.4%	$33.89B
CFCF Industries Holdings Inc.	$7.94B	+17.9%	$2.18B	27.5%	$18.07B
MOSMosaic Company	$11.90B	+0.0%	-$1.12B	-9.4%	$7.11B
ICLICL Group Ltd.	$7.15B	+4.6%	$226.00M	3.2%	$6.03B
UANCVR Partners LP	$659.46M	+7.3%	$106.41M	16.1%	$1.16B
CBUSCibus Inc.	$4.35M	-10.3%	-$98.19M	-2258.9%	$90.2M
AVDAmerican Vanguard Corporation	$510.32M	-3.5%	-$54.58M	-10.7%	$28.4M
BIOXBioceres Crop Solutions Corp.	$238.28M	-17.7%	-$263.94M	-110.8%	$14.7M

SMG FAQ

9 questions

What is SMG revenue?
Scotts Miracle-Gro Company (SMG) reported $3.48B of revenue for the twelve months ended Jun 27, 2026. That is up 4.6% from the year before. Revenue for fiscal 2025 was $3.41B.
Is SMG profitable?
Yes. Scotts Miracle-Gro Company earned $73.90M in net income for the twelve months ended Jun 27, 2026, a net margin of 2.1%.
How much cash and debt does SMG have?
Scotts Miracle-Gro Company reported $27.70M in cash and cash equivalents and $2.11B of debt on its most recent balance sheet in SEC filings.
How fast is SMG revenue growing?
Scotts Miracle-Gro Company's revenue changed -3.9% in fiscal 2025, to $3.41B. Its compound annual growth rate was -3.7% over 5 years and +3.7% over 10 years.
What is SMG gross margin?
Scotts Miracle-Gro Company's gross profit was $1.11B on $3.48B of revenue for the twelve months ended Jun 27, 2026, a gross margin of 31.8%.
What is SMG free cash flow?
Scotts Miracle-Gro Company generated $263.30M of free cash flow for the twelve months ended Jun 27, 2026, which is operating cash flow of $369.30M less capital expenditures.
What is SMG earnings per share?
Diluted earnings per share were $1.20 for the twelve months ended Jun 27, 2026, from SEC filings, restated for any stock split those filings show.
When did SMG last report financial results?
The latest statements here come from Scotts Miracle-Gro Company's 10-Q filed on Aug 5, 2026, covering the period ended Jun 27, 2026.
Where does this SMG financial data come from?
Quantisnow builds these statements from the structured XBRL data Scotts Miracle-Gro Company files with the SEC. It is provided for information only and is not investment advice.